Selected research
Industry Growth & Trends
Global Gene Expression Screening Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Gene Expression Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Gene Expression Screening Service market include EKF Diagnostics, Perkin Elmer, IntegraGen, Quest Diagnostics, Abbott Laboratories, Roche Diagnostics, Biocartis, Elitech Group and Interpace Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gene Expression Screening Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gene Expression Screening Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene Expression Screening Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene Expression Screening Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Gene Expression Screening Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gene Expression Screening Service Market by Company
EKF Diagnostics
Perkin Elmer
IntegraGen
Quest Diagnostics
Abbott Laboratories
Roche Diagnostics
Biocartis
Elitech Group
Interpace Diagnostics
Qiagen
AutoGenomics
Bio-Rad Laboratories
Cepheid
Gene Expression Screening Service Segment by Type
High-Throughput Screening
Low-Throughput Screening
Gene Expression Screening Service Segment by Application
Pharmaceutical Industry
Agricultural Industry
Environmental Science
Others
Gene Expression Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Expression Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Expression Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Expression Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Gene Expression Screening Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- High-Throughput Screening
- Low-Throughput Screening
Applications
- Pharmaceutical Industry
- Agricultural Industry
- Environmental Science
- Others
Companies covered
- EKF Diagnostics
- Perkin Elmer
- IntegraGen
- Quest Diagnostics
- Abbott Laboratories
- Roche Diagnostics
- Biocartis
- Elitech Group
- Interpace Diagnostics
- Qiagen
- AutoGenomics
- Bio-Rad Laboratories
- Cepheid
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Gene Expression Screening Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Gene Expression Screening Service Market Size by Region (2021-2032)
- 1.4.1 Global Gene Expression Screening Service Market Size by Region (2021-2026)
- 1.4.2 Global Gene Expression Screening Service Market Size by Region (2027-2032)
- 1.5 Key Regions Gene Expression Screening Service Market Size (2021-2032)
- 1.5.1 North America Gene Expression Screening Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Gene Expression Screening Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Gene Expression Screening Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Gene Expression Screening Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Gene Expression Screening Service Market Size Growth Rate (2021-2032)
2 Gene Expression Screening Service Market by Type
- 2.1 Type Introduction
- 2.1.1 High-Throughput Screening
- 2.1.2 Low-Throughput Screening
- 2.2 Global Gene Expression Screening Service Market Size by Type
- 2.2.1 Global Gene Expression Screening Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Gene Expression Screening Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Gene Expression Screening Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Gene Expression Screening Service Market Size by Regions
- 2.3.1 North America Gene Expression Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Gene Expression Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Gene Expression Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Gene Expression Screening Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Gene Expression Screening Service Market Size Breakdown by Type (2021-2026)
3 Gene Expression Screening Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Industry
- 3.1.2 Agricultural Industry
- 3.1.3 Environmental Science
- 3.1.4 Others
- 3.2 Global Gene Expression Screening Service Market Size by Application
- 3.2.1 Global Gene Expression Screening Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Gene Expression Screening Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Gene Expression Screening Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Gene Expression Screening Service Market Size by Regions
- 3.3.1 North America Gene Expression Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Gene Expression Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Gene Expression Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Gene Expression Screening Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Gene Expression Screening Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Gene Expression Screening Service Industry Trends
- 4.2 Gene Expression Screening Service Industry Drivers
- 4.3 Gene Expression Screening Service Industry Opportunities and Challenges
- 4.4 Gene Expression Screening Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Gene Expression Screening Service Revenue (2021-2026)
- 5.2 Global Gene Expression Screening Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Gene Expression Screening Service Key Company Headquarters & Area Served
- 5.4 Global Gene Expression Screening Service Company, Product Type & Application
- 5.5 Global Gene Expression Screening Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Gene Expression Screening Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Gene Expression Screening Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Gene Expression Screening Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 EKF Diagnostics
- 6.1.1 EKF Diagnostics Company Information
- 6.1.2 EKF Diagnostics Business Overview
- 6.1.3 EKF Diagnostics Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 EKF Diagnostics Gene Expression Screening Service Product Portfolio
- 6.1.5 EKF Diagnostics Recent Developments
- 6.2 Perkin Elmer
- 6.2.1 Perkin Elmer Company Information
- 6.2.2 Perkin Elmer Business Overview
- 6.2.3 Perkin Elmer Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Perkin Elmer Gene Expression Screening Service Product Portfolio
- 6.2.5 Perkin Elmer Recent Developments
- 6.3 IntegraGen
- 6.3.1 IntegraGen Company Information
- 6.3.2 IntegraGen Business Overview
- 6.3.3 IntegraGen Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 IntegraGen Gene Expression Screening Service Product Portfolio
- 6.3.5 IntegraGen Recent Developments
- 6.4 Quest Diagnostics
- 6.4.1 Quest Diagnostics Company Information
- 6.4.2 Quest Diagnostics Business Overview
- 6.4.3 Quest Diagnostics Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Quest Diagnostics Gene Expression Screening Service Product Portfolio
- 6.4.5 Quest Diagnostics Recent Developments
- 6.5 Abbott Laboratories
- 6.5.1 Abbott Laboratories Company Information
- 6.5.2 Abbott Laboratories Business Overview
- 6.5.3 Abbott Laboratories Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Abbott Laboratories Gene Expression Screening Service Product Portfolio
- 6.5.5 Abbott Laboratories Recent Developments
- 6.6 Roche Diagnostics
- 6.6.1 Roche Diagnostics Company Information
- 6.6.2 Roche Diagnostics Business Overview
- 6.6.3 Roche Diagnostics Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Roche Diagnostics Gene Expression Screening Service Product Portfolio
- 6.6.5 Roche Diagnostics Recent Developments
- 6.7 Biocartis
- 6.7.1 Biocartis Company Information
- 6.7.2 Biocartis Business Overview
- 6.7.3 Biocartis Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Biocartis Gene Expression Screening Service Product Portfolio
- 6.7.5 Biocartis Recent Developments
- 6.8 Elitech Group
- 6.8.1 Elitech Group Company Information
- 6.8.2 Elitech Group Business Overview
- 6.8.3 Elitech Group Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Elitech Group Gene Expression Screening Service Product Portfolio
- 6.8.5 Elitech Group Recent Developments
- 6.9 Interpace Diagnostics
- 6.9.1 Interpace Diagnostics Company Information
- 6.9.2 Interpace Diagnostics Business Overview
- 6.9.3 Interpace Diagnostics Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Interpace Diagnostics Gene Expression Screening Service Product Portfolio
- 6.9.5 Interpace Diagnostics Recent Developments
- 6.10 Qiagen
- 6.10.1 Qiagen Company Information
- 6.10.2 Qiagen Business Overview
- 6.10.3 Qiagen Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Qiagen Gene Expression Screening Service Product Portfolio
- 6.10.5 Qiagen Recent Developments
- 6.11 AutoGenomics
- 6.11.1 AutoGenomics Company Information
- 6.11.2 AutoGenomics Business Overview
- 6.11.3 AutoGenomics Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 AutoGenomics Gene Expression Screening Service Product Portfolio
- 6.11.5 AutoGenomics Recent Developments
- 6.12 Bio-Rad Laboratories
- 6.12.1 Bio-Rad Laboratories Company Information
- 6.12.2 Bio-Rad Laboratories Business Overview
- 6.12.3 Bio-Rad Laboratories Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Bio-Rad Laboratories Gene Expression Screening Service Product Portfolio
- 6.12.5 Bio-Rad Laboratories Recent Developments
- 6.13 Cepheid
- 6.13.1 Cepheid Company Information
- 6.13.2 Cepheid Business Overview
- 6.13.3 Cepheid Gene Expression Screening Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cepheid Gene Expression Screening Service Product Portfolio
- 6.13.5 Cepheid Recent Developments
7 North America
- 7.1 North America Gene Expression Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Gene Expression Screening Service Market Size by Country (2021-2026)
- 7.3 North America Gene Expression Screening Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Gene Expression Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Gene Expression Screening Service Market Size by Country (2021-2026)
- 8.3 Europe Gene Expression Screening Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Expression Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Gene Expression Screening Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Gene Expression Screening Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Gene Expression Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Gene Expression Screening Service Market Size by Country (2021-2026)
- 10.3 South America Gene Expression Screening Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Expression Screening Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Gene Expression Screening Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Gene Expression Screening Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst